logo
Plus   Neg
Share
Email

Swiss Re 9-month Group Net Income Rises

Reinsurer Swiss Re (SSREY.PK) on Thursday reported 23 percent growth in net income for the nine-month period, backed by growth in Reinsurance and an excellent investment result.

The Group's net income totaled $1.3 billion, compared to $1.1 billion a year ago. On a per share basis, earnings amounted to 4.52 cents, versus last year's 3.53 cents.

For nine months, net premiums earned and fee income rose by 10 percent to $28.4 billion, mainly driven by growth in P&C Re premiums.

The Group's ROE for the period was 6.0 percent versus 4.7 percent last year. Swiss Re reported an ROI of 4.3 percent, up from 2.8 percent in the same period a year earlier.

Swiss Re's Group CFO John Dacey said, "The Group's results in the first nine months underline the strength of our franchise. Despite multiple large natural catastrophe and man-made claims affecting the business, our capital position remains very strong..."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Global PC shipments returned to growth in the second quarter of 2020 after seeing a significant decline in the preceding first quarter due to COVID-19 related supply-chain disruptions, according to reports by two research firms. The PC market returned to growth in the quarter as production ramped up and vendors restocked their supplies to near-normal levels. The bankruptcy filing of America's oldest apparel retailer Brooks Brothers has ignited significant interest from potential buyers for the brand. WHP Global and a venture backed by Authentic Brands Group LLC and Simon Property Group, Inc., are reportedly considering bids for the retailer. WHP Global owns the ANNE KLEIN and JOSEPH ABBOUD brands. Sundial Herbal Products has recalled around 65 products, which were misbranded and currently unapproved drugs, the U.S. Food and Drug Administration said in a statement. The recall follows an order by a federal judge in June to stop distributing the company's unapproved new drugs. The affected items include herbal products and dietary supplements.
Follow RTT